AMKOR TECHNOLOGY, INC. (AMKR) FY2025 Q3 Balance Sheet
As of 2025-09-30
Balance Sheet
As of 2025-09-30
Swipe to see the full flow
Chart details
AMKOR TECHNOLOGY, INC. (AMKR) FY2025 Q3 Balance Sheet
Balance sheet as of 2025-09-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 8,187,482,000 US dollars
- Current assets
- 4,008,090,000 US dollars
- Non-current assets
- 4,179,392,000 US dollars
- Liabilities
- 3,844,538,000 US dollars
- Current liabilities
- 2,260,982,000 US dollars
- Non-current liabilities
- 1,583,556,000 US dollars
- Equity
- 4,342,944,000 US dollars
- Noncontrolling interest
- 34,578,000 US dollars. Included in consolidated equity; this amount is not added again.
- Cash and cash equivalents
- 1,495,656,000 US dollars
- Accounts receivable, net of allowances
- 1,399,446,000 US dollars
- Short-term investments (amortized cost of $613,568 and $513,494 in 2025 and 2024, respectively)
- 614,703,000 US dollars
- Inventories
- 399,892,000 US dollars
- Other current assets
- 98,393,000 US dollars
- Property, plant and equipment, net
- 3,833,008,000 US dollars
- Other assets
- 165,535,000 US dollars
- Operating lease right of use assets
- 101,015,000 US dollars
- Restricted cash
- 60,758,000 US dollars
- Goodwill
- 19,076,000 US dollars
- Trade accounts payable
- 925,268,000 US dollars
- Short-term borrowings and current portion of long-term debt
- 547,447,000 US dollars
- Accrued expenses
- 395,294,000 US dollars
- Capital expenditures payable
- 368,308,000 US dollars
- Short-term operating lease liability
- 24,665,000 US dollars
- Long-term debt
- 1,264,501,000 US dollars
- Other non-current liabilities
- 181,633,000 US dollars
- Pension and severance obligations
- 82,996,000 US dollars
- Long-term operating lease liabilities
- 54,426,000 US dollars
- Retained earnings
- 2,475,936,000 US dollars
- Additional paid-in capital
- 2,047,017,000 US dollars
- Accumulated other comprehensive income (loss)
- 11,889,000 US dollars
- Common stock, $0.001 par value, 500,000 shares authorized; 293,636 and 293,052 shares issued; and 247,192 and 246,684 shares outstanding in 2025 and 2024, respectively
- 294,000 US dollars
- Preferred stock, $0.001 par value, 10,000 shares authorized, designated Series A, none issued
- 0 US dollars
- Non-controlling interests in subsidiaries
- 34,578,000 US dollars
- Treasury stock, at cost, 46,444 and 46,368 shares in 2025 and 2024, respectively
- negative 226,770,000 US dollars
- Gross equity (calculated)
- 4,569,714,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
